1st Quarter - Report

CELGENE CORPORATION for CELGENE CORPORATION

Firm
Client
Income
—
Expenses
$1,030,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

- Corporate Tax Reform including House BluePrint and Border Adjustablity.

LobbyistCovered position, as disclosed
PATRICK GLIHA —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

- Issues related to Medicare Part D/Part B, the Affordable Care Act, Regulation of Non-Biological Complex Drugs, TRICARE, & Step Therapy/Fail First. - Issues related to HR 2841, "FAST Generic Act of 2015", regarding risk evaluation and mitigation strategy. - Issues related to HR 2739/S 1566, "Cancer Drug Coverage Parity Act". - Issues related to HR 1600, "Patients Access To Treatments Act". - Issues related to S 3056, "CREATES Act of 2016", regarding REMS.

LobbyistCovered position, as disclosed
PATRICK GLIHA —
MATTHEW SCHUMAKER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2841 (115th), H.R. 2739 (115th), H.R. 1600 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.